Načítá se...
The endocannabinoid system as a target for novel anxiolytic drugs
The endocannabinoid (eCB) system has attracted attention for its role in various behavioral and brain functions, and as a therapeutic target in neuropsychiatric disease states, including anxiety disorders and other conditions resulting from dysfunctional responses to stress. In this mini-review, we...
Uloženo v:
| Vydáno v: | Neurosci Biobehav Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5407316/ https://ncbi.nlm.nih.gov/pubmed/28434588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neubiorev.2016.12.033 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|